Figure S6 from Immune Activation in Patients with Locally Advanced Cervical Cancer Treated with Ipilimumab Following Definitive Chemoradiation (GOG-9929)

MLA

W. Martin Kast, et al. Figure S6 from Immune Activation in Patients with Locally Advanced Cervical Cancer Treated with Ipilimumab Following Definitive Chemoradiation (GOG-9929). Mar. 2023. EBSCOhost, https://doi.org/10.1158/1078-0432.22476128.v1.

APA

W. Martin Kast, Michael J. Birrer, Russell J. Schilder, Yvonne G. Lin, Sharad A. Ghamande, Katherine M. Moxley, Heather A. Lankes, Huyen Q. Pham, Koji Matsuo, Joseph G. Skeate, Jyoti S. Mayadev, Danielle M. Enserro, & Diane M. Da Silva. (2023). Figure S6 from Immune Activation in Patients with Locally Advanced Cervical Cancer Treated with Ipilimumab Following Definitive Chemoradiation (GOG-9929). https://doi.org/10.1158/1078-0432.22476128.v1

Chicago

W. Martin Kast, Michael J. Birrer, Russell J. Schilder, Yvonne G. Lin, Sharad A. Ghamande, Katherine M. Moxley, Heather A. Lankes, et al. 2023. “Figure S6 from Immune Activation in Patients with Locally Advanced Cervical Cancer Treated with Ipilimumab Following Definitive Chemoradiation (GOG-9929),” March. doi:10.1158/1078-0432.22476128.v1.